AstraZeneca plc vs Modine Manufacturing Company — how do they compare? AstraZeneca plc trades at $158.11 (market cap $248.14B), while Modine Manufacturing Company trades at $202.06 (market cap $10.53B). The key difference: AstraZeneca plc is far larger — about 23.6× Modine Manufacturing Company's market cap, and AstraZeneca plc pays a 2.01% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.
| AZN | MOD | |
|---|---|---|
Market Cap | $248.14B | $10.53B |
Sector | Health | Technology |
52-Week High | $209.48 | $306.89 |
52-Week Low | $147.06 | $119.68 |
Enterprise Value | $275.41B | $10.97B |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →